293 related articles for article (PubMed ID: 11413302)
1. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
[TBL] [Abstract][Full Text] [Related]
2. In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model.
Cao T; Meuleman P; Desombere I; Sällberg M; Leroux-Roels G
J Virol; 2001 Dec; 75(23):11449-56. PubMed ID: 11689626
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
Lazdina U; Cao T; Steinbergs J; Alheim M; Pumpens P; Peterson DL; Milich DR; Leroux-Roels G; Sällberg M
J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303
[TBL] [Abstract][Full Text] [Related]
4. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
5. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
6. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.
Lue C; Kiyono H; Fujihashi K; McGhee JR; Mestecky J
Reg Immunol; 1992; 4(2):86-90. PubMed ID: 1503891
[TBL] [Abstract][Full Text] [Related]
7. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
8. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific human immunoglobulin production in SCID mice transplanted with human peripheral lymphocytes is dependent on CD4+ CD45RO+ T cells.
Mårtensson C; Kristensson K; Kalliomäki S; Borrebaeck CA; Carlsson R
Immunology; 1994 Oct; 83(2):171-9. PubMed ID: 7835932
[TBL] [Abstract][Full Text] [Related]
10. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
11. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice.
Milich DR; Jones JE; Hughes JL; Maruyama T; Price J; Melhado I; Jirik F
J Immunol; 1994 Jan; 152(2):455-66. PubMed ID: 8283030
[TBL] [Abstract][Full Text] [Related]
12. Human Ig production and isotype switching in severe combined immunodeficient-human mice.
Vandekerckhove BA; Jones D; Punnonen J; Schols D; Lin HC; Duncan B; Bacchetta R; de Vries JE; Roncarolo MG
J Immunol; 1993 Jul; 151(1):128-37. PubMed ID: 8326122
[TBL] [Abstract][Full Text] [Related]
13. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
Jackson DJ; Kumpel BM
Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
[TBL] [Abstract][Full Text] [Related]
14. Comparative immunogenicity of hepatitis B virus core and E antigens.
Milich DR; McLachlan A; Stahl S; Wingfield P; Thornton GB; Hughes JL; Jones JE
J Immunol; 1988 Nov; 141(10):3617-24. PubMed ID: 2460543
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human IgE response in hu-PBL-SCID mice.
Kilchherr E; Mandak V; Wagner K; Heusser CH
Cell Immunol; 1993 Oct; 151(2):241-56. PubMed ID: 8402934
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of specific immunoglobulin production in SCID-hu-PBL mice after in vitro priming of human B cells with superantigen.
Mårtensson C; Ifversen P; Borrebaeck CA; Carlsson R
Immunology; 1995 Oct; 86(2):224-30. PubMed ID: 7490122
[TBL] [Abstract][Full Text] [Related]
17. Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.
Takashima H; Araki K; Miyazaki J; Yamamura K; Kimoto M
Immunology; 1992 Mar; 75(3):398-405. PubMed ID: 1533387
[TBL] [Abstract][Full Text] [Related]
18. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.
Carballido JM; Schols D; Namikawa R; Zurawski S; Zurawski G; Roncarolo MG; de Vries JE
J Immunol; 1995 Nov; 155(9):4162-70. PubMed ID: 7594571
[TBL] [Abstract][Full Text] [Related]
19. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
20. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]